GLADIUS THERAPEUTICS Trademark
        
        
          Trademark Overview
          
          On Thursday, August 3, 2023, a trademark application was filed for GLADIUS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GLADIUS THERAPEUTICS trademark a serial number of 98114878. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 3, 2025. This trademark is owned by Gladius Therapeutics, Inc.. The GLADIUS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of cancer
Research and development in the field of pharmaceuticals and oncology for treatment of cancer
         
        
          General Information
          
          
          	| Serial Number | 98114878 | 
			| Word Mark | GLADIUS THERAPEUTICS | 
            | Filing Date | Thursday, August 3, 2023 | 
			| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED | 
			| Status Date | Monday, February 3, 2025 | 
            | Registration Number | 0000000 | 
            | Registration Date | NOT AVAILABLE | 
            | Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) | 
            | Published for Opposition Date | Tuesday, May 7, 2024 | 
          
         
        
          Trademark Statements
          
		  
            | Description of Mark | The mark consists of the stylized word "GLADIUS" positioned above the stylized word "THERAPEUTICS", all of which is positioned to the right of a geometric design comprised of an incomplete polygonal design positioned below a horizontal line design. The colors black and white represent background, outlining, shading, and transparent areas and are not claimed as features of the mark. | 
| Goods and Services | Pharmaceutical preparations for the treatment of cancer | 
| NOT AVAILABLE | "THERAPEUTICS" | 
| Goods and Services | Research and development in the field of pharmaceuticals and oncology for treatment of cancer | 
          
         
        
          Classification Information
          
		  | International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | 
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 | 
| Class Status Code | 6 - Active | 
| Class Status Date | Thursday, August 31, 2023 | 
| Primary Code | 005 | 
| First Use Anywhere Date | NOT AVAILABLE | 
| First Use In Commerce Date | NOT AVAILABLE | 
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | 
| US Class Codes | 100, 101 | 
| Class Status Code | 6 - Active | 
| Class Status Date | Thursday, August 31, 2023 | 
| Primary Code | 042 | 
| First Use Anywhere Date | NOT AVAILABLE | 
| First Use In Commerce Date | NOT AVAILABLE | 
         
        
          Trademark Owner History
          
		  | Party Name | Gladius Therapeutics, Inc. | 
| Party Type | 20 - Owner at Publication | 
| Legal Entity Type | 03 - Corporation | 
| Address | Philadelphia, PA 19104 | 
| Party Name | Gladius Therapeutics, Inc. | 
| Party Type | 10 - Original Applicant | 
| Legal Entity Type | 03 - Corporation | 
| Address | Philadelphia, PA 19104 | 
         
        
          Trademark Events
          
		  
          	| Event Date | Event Description | 
            | Monday, August 7, 2023 | NEW APPLICATION ENTERED | 
| Friday, September 1, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED | 
| Thursday, April 4, 2024 | ASSIGNED TO EXAMINER | 
| Thursday, April 4, 2024 | EXAMINERS AMENDMENT -WRITTEN | 
| Thursday, August 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 
| Thursday, April 4, 2024 | EXAMINERS AMENDMENT E-MAILED | 
| Thursday, April 4, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 
| Thursday, April 4, 2024 | EXAMINER'S AMENDMENT ENTERED | 
| Wednesday, April 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 
| Tuesday, May 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 
| Tuesday, July 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 
| Monday, February 3, 2025 | ABANDONMENT - NO USE STATEMENT FILED | 
| Monday, February 3, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 
| Tuesday, May 7, 2024 | PUBLISHED FOR OPPOSITION | 
| Thursday, April 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |